Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Sterling TR, Moro RN, Borisov AS, Phillips E, Shepherd G, Adkinson NF, Weis S, Ho C, Villarino ME, Tuberculosis Trials Consortium
Clin Infect Dis. 2015 61 (4): 527-35

PMID: 25904367 · PMCID: PMC4560029 · DOI:10.1093/cid/civ323

MeSH Terms (13)

Adolescent Adult Antitubercular Agents Drug-Related Side Effects and Adverse Reactions Female Humans Isoniazid Latent Tuberculosis Male Middle Aged Prospective Studies Respiratory Tract Diseases Rifampin

Connections (2)

This publication is referenced by other Labnodes entities: